States Offering Partial GLP-1 Coverage for Obesity: Another 22 states, including Texas, Arizona, and Washington, offer partial coverage for obesity-specific GLP-1s
Effective integration of PGx into clinical practice can make well-supported, accessible data a standard part of care
Instead of quitting entirely, patients taper down to a maintenance microdose. This keeps the drug in their system just enough to curb the loudest food noise
Feel uneasy about the potential risks of compounded medications, like dosage variability or shipping issues
Not for human consumption, veterinary use, or diagnostic applications
Its important for patients to understand that GLP-1 medications are not a skinny shot, but a tool designed to support metabolic health through long-term weight management